BELGRADE, Mont. , July 26, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the expansion of its tissue processing facility in Belgrade, MT , which now includes an additional

Second Quarter 2016 Revenue in the range of $21.45 million to $21.65 million Core recurring revenue to increase 5.6% to 6.6% over the same period last year EBITDA projected to be $300,000-$400,000 for Second Quarter 2016 BELGRADE, Mont. , July 20, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings,

BELGRADE, Mont. , July 19, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the period ended June 30th 2016, at the close of the

BELGRADE, Mont. , June 16, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced the appointment of Paul Buckman , Eric Timko , and Rudy Mazzocchi to its Board of Directors.  The

BELGRADE, Mont. and DALLAS , June 08, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices and Pinnacle Spine Group, LLC , a developer of innovative spinal fusion solutions, today announced a joint

New facility provides additional working capital to continue Company market expansion plans BELGRADE, Mont. , May 26, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international

BELGRADE, Mont. , May 17, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), formerly Bacterin International Holdings, Inc. , a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that its Chief

BELGRADE, Mont. , May 13, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, has established a record date for its 2016 annual meeting of stockholders.

BELGRADE, Mont. , May 12, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices, today announced FDA clearance for the posterior cervical screw indication on the Certex® Spinal Fixation System.

See footnote about the use of pro forma financial information First Quarter 2016 Highlights: Core recurring revenue (excluding OEM and other revenue) increased 6.8% to $20.5 million compared to core pro forma recurring revenue of $19.2 million in first quarter 2015 Gross profit increased slightly